Enveric Biosciences, Inc. ENVB

Full chart Compare
Set alert

Price alert · ENVB

All alert types
1.46 USD -0.04 (-2.67%)

At closeNov 4, 2026, 4:00 PM EST

1.44 -0.02 -1.37%

After hours · Nov 4, 4:00 PM ET

1.43 Day range 1.58
1.17 52-week range 13.25
YTD
-59.78%
1 year
-74.39%

Revenue & Expenses

Revenue → Gross Profit: $8.98MGross Profit → Expenses: $8.98MRevenue → Cost of Revenue: $34.01MExpenses → Selling, General & Admin: $10.79MExpenses → Other Operating Expenses: $5.34MExpenses → Interest Expense: $729.90KExpenses → Other Expenses: $2.67MExpenses → Income Tax: $6.35MNet Loss → Expenses: $16.90MGross Profit$8.98MNet Loss$16.90MCost of Revenue$34.01MExpenses$25.88MSelling, General & Admin$10.79MOther Operating Expenses$5.34MInterest Expense$729.90KOther Expenses$2.67MIncome Tax$6.35MRevenue$43.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ENVB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-8.77M-9.63M-16.45M-27.42M-64.62M
-8.77M-9.57M-17.29M-18.47M-48.98M
-36.24-228.48-1,455.00-2,340.00-18,664.00
ENVB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.68M2.24M2.29M17.72M17.36M
5.10M3.08M4.30M19.55M26.72M
918.40K1.49M2.34M4.88M4.41M
4.18M1.59M1.96M14.67M22.31M
ENVB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-8.14M-7.73M-14.09M-17.15M-11.46M
10.58M7.67M-1.34M18.18M24.90M
2.44M-46.95K-15.44M367.88K15.78M